Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Generic version of Plavix launched in US

August 10, 2006 Sales and Marketing

A generic company has launched a version of blood-thinning blockbuster product Plavix in the US, threatening the $3.3 billion sales …
News

GSK delivers strong quarterly performance

August 9, 2006 Sales and Marketing

GlaxoSmithKline's pharmaceutical sales rose by 10% in this year's second quarter earning the company a total of five billion pounds.Sales …
News

Lilly’s new products drive up sales

August 8, 2006 Sales and Marketing

Accelerated sales of predicted blockbuster depression treatment Cymbalta have helped boost Lilly sales for the second quarter of 2006.The drug …
News

Identifying and nurturing talent in your salesforce

August 7, 2006 Sales and Marketing Schering-Plough, UK, sales, strategy

The aim of every company, pharma or otherwise, is to boost sales and take a greater market share. However, despite …
Feature

Takeda selects London for new European business

August 4, 2006 Sales and Marketing

Japanese pharmaceutical company Takeda has chosen London as the site of its new four million pound European sales and marketing …
News

McKinnell makes early exit from Pfizer

August 3, 2006 Sales and Marketing Pfizer

Hank McKinnell has stepped down as chief executive of Pfizer earlier than expected following continued criticism of his performance from …
Feature

Pfizer’s Sutent receives conditional EMEA approval

August 3, 2006 Sales and Marketing

 Pfizer's new kidney cancer drug Sutent is rapidly catching up with its recently approved rival, Bayer's Nexavar.Sutent (sunitinib) has been …
News

Crestor leads AZ European sales growth

August 3, 2006 Sales and Marketing

Crestor was AstraZeneca's most rapidly expanding product in terms of European sales in the second quarter of this year.  Sales …
News

Pfizer’s smoking-cessation drug a step closer to European approval

August 3, 2006 Sales and Marketing

Pfizer's potential blockbuster smoking cessation drug Champix has been recommended for European approval by a key EMEA committee.The first-in-class treatment …
News

Study boost for AstraZeneca’s Nexium

August 1, 2006 Sales and Marketing

AstraZeneca's blockbuster gastro-oesophageal reflux disease treatment Nexium has come out ahead of Wyeth's Zoton in a new study, which showed …
News

First cervical cancer vaccine close to European approval

August 1, 2006 Sales and Marketing

The first-ever cervical cancer vaccine is set for approval in Europe following its recommendation from a key advisory committee.The positive …
News

Market Research…..our survey said

July 31, 2006 Sales and Marketing market research

Marrying traditional techniquesDespite researchers' natural leaning towards either qualitative or quantitative research, it is clear that the two types of …
Feature

Wyeth looks for European boost from Enbrel NICE guidance

July 27, 2006 Sales and Marketing

Wyeth's Enbrel has received a dual recommendation from NICE – guidance the pharma company hopes will influence healthcare decisions elsewhere …
News

Nexavar gets EU go-ahead in advanced kidney cancer

July 27, 2006 Sales and Marketing

Bayer has received the green light from European regulators for Nexavar to treat the most common type of kidney cancer …
News

Novartis speeds up Tasigna programme

July 25, 2006 Sales and Marketing

Novartis' new cancer drug will be submitted earlier than expected for European and US approval after showing positive results in …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026